companydata.dkcompanydata.dk

MAXIPHARMA A/S: Financial statements 2015

CVR: 87375617

Source: annual report 2015, Danish Business Authority

01/01/201531/12/2015

MAXIPHARMA A/S (CVR 87375617) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 1,154,410 and a net result of DKK -187,595 compared with DKK 507,816 the year before. That is a decrease of 30.7% compared with the year before. Equity in the 2015 report amounted to DKK 2,197,156. The solvency ratio was 49.8%. The company had 2 employees in the financial year.

Gross Profit
DKK 1,154,410
Profit/Loss
DKK -187,595
Equity
DKK 2,197,156
Total Assets
DKK 4,412,922
Employees
2

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2015-1.2 mio.-188 t.2.2 mio.2
2014-1.7 mio.508 t.2.6 mio.2
2013-973 t.-222 t.2.1 mio.-
2012-1.5 mio.740 t.2.3 mio.2

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is MAXIPHARMA A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2015

MAXIPHARMA A/S: The 2014 annual report is outMay 27, 2015

MAXIPHARMA A/S has published its annual report for 2014. Gross profit came to DKK 1,666,635, and the net result was DKK 507,816.

About MAXIPHARMA A/S

MAXIPHARMA A/S is a Danish company of the type Aktieselskab based in Højbjerg, founded in 1979. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Jesper Bjerre Jensen. The board consists of Benedikte Mailand Jensen (chair), Henrik Bencke and Jesper Bjerre Jensen. The company is owned by AKTIESELSKABET SGJ. The company has 2 employees (2018). In 2025, the company reported a gross profit of DKK 1,791,625 and a net result of DKK 434,996 compared with DKK 411,322 the year before. Equity in the 2025 report amounted to DKK 4,204,696.

Source: annual report 2025, Danish Business Authority